Higher Selection Pressure from Antiretroviral Drugs in Vivo Results in Increased Evolutionary Distance in HIV-1 pol
- 1 June 1999
- Vol. 259 (1) , 154-165
- https://doi.org/10.1006/viro.1999.9774
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Comparative Performance of High-Density Oligonucleotide Sequencing and Dideoxynucleotide Sequencing of HIV Type 1polfrom Clinical SamplesAIDS Research and Human Retroviruses, 1998
- Mutations in thepolGene of Human Immunodeficiency Virus Type 1 in Infected Patients Receiving Didanosine and Hydroxyurea Combination TherapyThe Journal of Infectious Diseases, 1997
- HIV-1 Evolution and Disease ProgressionScience, 1996
- Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 InfectionAnnals of Internal Medicine, 1996
- Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure.Proceedings of the National Academy of Sciences, 1996
- Possible involvement of cell fusion and viral recombination in generation of human immunodeficiency virus variants that display dual resistance to AZT and 3TCJournal of General Virology, 1995
- HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and TherapyScience, 1995
- Dilution assay statisticsJournal of Clinical Microbiology, 1994
- Rapid fitness losses in mammalian RNA virus clones due to Muller's ratchet.Proceedings of the National Academy of Sciences, 1992
- Fitness of RNA virus decreased by Muller's ratchetNature, 1990